Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |